Reaching low density lipoprotein cholesterol targets

Abstract

Cardiovascular disease is a major health problem and within the leading causes of death worldwide. Low-density lipoprotein cholesterol (LDL-C) is strongly associated with the development and progression of cardiovascular disease and is among the main targets of lipid lowering therapy. Despite the various lipid lowering agents for the management of hyperlipidemia, a significant number of patients do not reach their LDL-C target goals. Data from studies in various world regions identify an often poor achievement of LDL-C goals, especially in high risk patient groups. The causes of this suboptimal management of hyperlipidemia are multifactorial and measures should be taken in order to identify and address these shortcomings in dyslipidemia therapy.

Keywords::

• Cardiovascular disease
• Lipid lowering therapy
• Low density lipoprotein cholesterol
• Risk factors

Transparency

Declaration of funding

This editorial was not funded.

Declaration of financial/other relationships

All authors have disclosed that they have no significant relationships with or financial interests in any commercial companies related to this study or article.